Invesco Portfolio holdings
Invesco is an investment management company that launched the Invesco QQQ exchange-traded fund in 1999, back when it operated as Amvescap. Invesco QQQ tracks the Nasdaq-100 index of companies listed on Nasdaq. Invesco traces its roots to H. Lotery & Co., a UK advisory firm formed in 1935, and in 1978 Charles Brady and eight partners bought the money management arm of Citizens & Southern National Bank, then called INVESCO. It bought PowerShares Capital Management, sponsor of 36 exchange-traded funds, in 2006, and in 2007 it went back to the Invesco name and moved its legal home to Bermuda. Its 2009 purchase of Morgan Stanley's retail unit brought in Van Kampen Investments, and in 2019 it acquired OppenheimerFunds from Massachusetts Mutual Life Insurance Company. It serves retail and institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$6.35B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$2.84B |
| 3 |
Arm
ARM
|
+$1.84B |
| 4 |
Lumentum
LITE
|
+$1.78B |
| 5 |
Teradyne
TER
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.26B |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2B |
| 3 |
Honeywell
HON
|
+$2.2B |
| 4 |
Dell
DELL
|
+$1.69B |
| 5 |
Insmed
INSM
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 9.38% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.59% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3476
Avidia Bancorp
AVBC
$417M
| $227K | ﹤0.01% |
+10,837
| New | +$216K |
2026 Q2
0 quarters
|
|
3477
Neuropace
NPCE
$422M
| $227K | ﹤0.01% |
14,302
+3,628
| +34% | +$58.4K |
2025 Q4
2 quarters
|
|
3478
Sable Offshore Corp
SOC
$528M
| $226K | ﹤0.01% |
73,381
-239,488
| -77% | -$3.05M |
2024 Q2
8 quarters
|
|
3479
SEACOR Marine Holdings
SMHI
$268M
| $225K | ﹤0.01% |
29,445
+139
| +0.5% | +$1.03K |
2023 Q3
11 quarters
|
|
3480
Immersion
IMMR
$239M
| $225K | ﹤0.01% |
33,232
+4,408
| +15% | +$27.8K |
2023 Q2
12 quarters
|
|
3481
Proficient Auto Logistics
PAL
$73.5M
| $225K | ﹤0.01% |
33,022
+8,372
| +34% | +$56K |
2025 Q4
2 quarters
|
|
3482
NewAmsterdam Pharma
NAMS
$2.4B
| $224K | ﹤0.01% |
6,617
-674
| -9% | -$22.2K |
2024 Q4
6 quarters
|
|
3483
Delcath Systems
DCTH
$487M
| $224K | ﹤0.01% |
17,787
+650
| +4% | +$7.19K |
2025 Q1
5 quarters
|
|
3484
Bobs Discount Furniture
BOBS
$2.17B
| $224K | ﹤0.01% |
+14,137
| New | +$176K |
2026 Q2
0 quarters
|
|
3485
EHang Holdings
EH
$272M
| $223K | ﹤0.01% |
34,102
-4,431
| -11% | -$41.3K |
2021 Q1
21 quarters
|
|
3486
One Stop Systems
OSS
$129M
| $222K | ﹤0.01% |
+12,209
| New | +$170K |
2026 Q2
0 quarters
|
|
3487
Newsmax Inc
NMAX
$1.04B
| $222K | ﹤0.01% |
26,801
-41,409
| -61% | -$297K |
2025 Q4
2 quarters
|
|
3488
iShares S&P 100 ETF
OEF
$20B
| $221K | ﹤0.01% |
+604
| New | +$216K |
2026 Q2
0 quarters
|
|
3489
Generate Biomedicines
GENB
$1.86B
| $221K | ﹤0.01% |
+13,087
| New | +$178K |
2026 Q2
0 quarters
|
|
3490
Minerva Neurosciences
NERV
$111M
| $220K | ﹤0.01% |
+39,689
| New | +$215K |
2026 Q2
0 quarters
|
|
3491
Tectonic Therapeutic
TECX
$387M
| $220K | ﹤0.01% |
6,388
-1,287
| -17% | -$37.8K |
2026 Q1
1 quarter
|
|
3492
Power Solutions International
PSIX
$1.05B
| $219K | ﹤0.01% |
5,639
-2,754
| -33% | -$151K |
2025 Q2
4 quarters
|
|
3493
Atlanta Braves Holdings Series A
BATRA
$3.51B
| $219K | ﹤0.01% |
+3,891
| New | +$207K |
2026 Q2
0 quarters
|
|
3494
Opus Genetics
IRD
$305M
| $219K | ﹤0.01% |
+53,231
| New | +$248K |
2026 Q2
0 quarters
|
|
3495
Future Fuel
FF
$249M
| $219K | ﹤0.01% |
48,362
-4,315
| -8% | -$18.6K |
2013 Q2
52 quarters
|
|
3496
Monopar Therapeutics
MNPR
$472M
| $218K | ﹤0.01% |
+2,356
| New | +$146K |
2026 Q2
0 quarters
|
|
3497
Vanguard Extended Market ETF
VXF
$30B
| $217K | ﹤0.01% |
883
-97
| -10% | -$22.2K |
2025 Q3
3 quarters
|
|
3498
Douglas Elliman
DOUG
$141M
| $217K | ﹤0.01% |
122,604
-36,143
| -23% | -$64.8K |
2021 Q4
18 quarters
|
|
3499
Precision BioSciences
DTIL
$195M
| $217K | ﹤0.01% |
+27,582
| New | +$194K |
2026 Q2
0 quarters
|
|
3500
Grindr
GRND
$2.2B
| $217K | ﹤0.01% |
15,084
-3,229
| -18% | -$41.8K |
2023 Q2
12 quarters
|
|
Similar funds
Invesco's Q2 2026 Portfolio in Review
As of Q2 2026, Invesco held 3,969 positions worth $1.26T, up 23% from $1.02T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invesco's Q2 2026 filing shows 214 new, 1,806 increased, 1,705 reduced and 150 closed positions. Its largest new stake was Honeywell Aerospace: 12,884,435 shares worth $2.85B. The largest sale was Invesco NASDAQ 100 ETF, an estimated $2.26B.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Invesco's largest Q2 2026 buy was Honeywell Aerospace: 12,884,435 shares worth $2.85B.
- Invesco added most to Sandisk in Q2 2026, an estimated $6.35B increase.
- Invesco's biggest Q2 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $2.26B.
- Invesco fully exited Coterra Energy in Q2 2026, selling an estimated $394M.
- Invesco's ten largest holdings make up 29% of its $1.26T portfolio in Q2 2026.
- Invesco opened 214 new positions and closed 150 in Q2 2026.
- Invesco's portfolio value rose 23% quarter-over-quarter to $1.26T.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.